Medinotec (MDNC) Income from Continuing Operations (2022 - 2026)
Medinotec (MDNC) posted Income from Continuing Operations of 208499.0 for Q2 2026, down 57.88% on a QoQ basis from 494986.0 in Q1 2026, and down 60.33% year-over-year from 525618.0 in Q2 2025.
Medinotec (MDNC) Income from Continuing Operations (2022 - 2026) Analysis & Trends
Medinotec's Income from Continuing Operations history runs 5 years deep, the most recent figure standing at 208499.0 for Q2 2026.
- Quarterly Income from Continuing Operations fell 60.33% year-over-year to 208499.0 in Q2 2026, while the trailing twelve-month figure through May 2026 was 1680210.0 (down 66.88% YoY) and the FY2026 annual result came in at 1343872.0, down 65.44% from the prior year.
- Income from Continuing Operations was 208499.0 for Q2 2026 at Medinotec, down from 494986.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 4330789.0 in Q1 2025 and bottomed at 492371.0 in Q4 2023.
- A 5-year average of 366807.61 and a median of 121872.5 in 2023 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2023 — Income from Continuing Operations plunged 2342.02% — and 2024, when it surged 1612.8%.
- Medinotec's Income from Continuing Operations stood at 21961.0 in 2022, then plunged by 2342.02% to 492371.0 in 2023, then surged by 167.53% to 332486.0 in 2024, then dropped by 26.02% to 245961.0 in 2025, then dropped by 15.23% to 208499.0 in 2026.
- Business Quant data shows MDNC's Income from Continuing Operations at 208499.0 in Q2 2026, 494986.0 in Q1 2026, and 245961.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Medinotec | 58.78 Mn | 58.19 Mn | 1.31 Mn | 208,499.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 208,499.00 |
| Feb 28, 2026 | 494,986.00 |
| Nov 30, 2025 | 245,961.00 |
| Aug 31, 2025 | 730,764.00 |
| May 31, 2025 | 525,618.00 |
| Feb 28, 2025 | 4.33 Mn |
| Nov 30, 2024 | 332,486.00 |
| Aug 31, 2024 | -115,928.00 |
| May 31, 2024 | 314,299.00 |
| Feb 29, 2024 | 330,676.00 |
| Nov 30, 2023 | -492,371.00 |
| Aug 31, 2023 | -44,034.00 |
| May 31, 2023 | 18,350.00 |
| Feb 28, 2023 | 35,246.00 |
| Nov 30, 2022 | 21,961.00 |
| Aug 31, 2022 | -219,294.00 |
| May 31, 2022 | 8,528.00 |
| Feb 28, 2022 | -123,999.00 |